Thomas Rozario - Search Results

Year	Number of Results
2016	1
2017	3
2018	2
2019	1
2020	1
2023	0

1

No Matter How You Splice It, RBM39 Inhibition Targets Spliceosome Mutant AML.

Thomas R, Majeti R. Thomas R, et al. Cancer Cell. 2019 Mar 18;35(3):337-339. doi: 10.1016/j.ccell.2019.02.013. Cancer Cell. 2019. PMID: 30889374 Free article.

2

Whole chromosome loss and associated breakage-fusion-bridge cycles transform mouse tetraploid cells.

Thomas R, Marks DH, Chin Y, Benezra R. Thomas R, et al. EMBO J. 2018 Jan 17;37(2):201-218. doi: 10.15252/embj.201797630. Epub 2017 Dec 1. EMBO J. 2018. PMID: 29196303 Free PMC article.

3

Mad2 Overexpression Uncovers a Critical Role for TRIP13 in Mitotic Exit.

Marks DH, Thomas R, Chin Y, Shah R, Khoo C, Benezra R. Marks DH, et al. Among authors: thomas r. Cell Rep. 2017 May 30;19(9):1832-1845. doi: 10.1016/j.celrep.2017.05.021. Cell Rep. 2017. PMID: 28564602 Free PMC article.

4

Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target.

Cook PJ, Thomas R, Kannan R, de Leon ES, Drilon A, Rosenblum MK, Scaltriti M, Benezra R, Ventura A. Cook PJ, et al. Among authors: thomas r. Nat Commun. 2017 Jul 11;8:15987. doi: 10.1038/ncomms15987. Nat Commun. 2017. PMID: 28695888 Free PMC article.

5

Integrated analysis of patient samples identifies biomarkers for venetoclax efficacy and combination strategies in acute myeloid leukemia.

Zhang H, Nakauchi Y, Köhnke T, Stafford M, Bottomly D, Thomas R, Wilmot B, McWeeney SK, Majeti R, Tyner JW. Zhang H, et al. Among authors: thomas r. Nat Cancer. 2020 Aug;1(8):826-839. doi: 10.1038/s43018-020-0103-x. Epub 2020 Aug 18. Nat Cancer. 2020. PMID: 33123685 Free PMC article.

6

Cox-2-derived PGE2 induces Id1-dependent radiation resistance and self-renewal in experimental glioblastoma.

Cook PJ, Thomas R, Kingsley PJ, Shimizu F, Montrose DC, Marnett LJ, Tabar VS, Dannenberg AJ, Benezra R. Cook PJ, et al. Among authors: thomas r. Neuro Oncol. 2016 Oct;18(10):1379-89. doi: 10.1093/neuonc/now049. Epub 2016 Mar 28. Neuro Oncol. 2016. PMID: 27022132 Free PMC article.

7

Author Correction: Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target.

Cook PJ, Thomas R, Kannan R, de Leon ES, Drilon A, Rosenblum MK, Scaltriti M, Benezra R, Ventura A. Cook PJ, et al. Among authors: thomas r. Nat Commun. 2018 Mar 13;9:16187. doi: 10.1038/ncomms16187. Nat Commun. 2018. PMID: 29532792 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

7 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year